Modified Activated Carbon for Copper Ion Removal from Aqueous Solution

Because of increasing environmental awareness, it is becoming more important to remove harmful elements from water solutions. This study used activated carbon (AC) derived from waste wood-based panels as the base material, oxidized with nitric acid (OAC), and grafted with iminodiacetic acid (IDA-OAC) to improve the adsorption capacity and affinity for metals. The characterization of AC, OAC, and IDA-OAC was conducted via FTIR, SEM, N2 adsorption and desorption analysis, elemental analysis, Boehm titration, and point of zero charge (PZC). The instrument studies proved the modified increasing of the functional groups of the adsorbents. Moreover, batch and column experiments were conducted to evaluate the ability of the three adsorbents to remove copper ions from aqueous solution. In batch sorption, IDA-OAC had the highest adsorption capacity (84.51 mg/g) compared to OAC (54.74 mg/g) and AC (24.86 mg/g) at pH 5. The breakthrough point (Ct/Ci = 0.05) of copper ions for IDA-OAC occurred much later than AC in the column experiment (AC = 19 BV, IDA-OAC = 52 BV). The Langmuir isotherm and pseudo-second-model kinetics modeling could better fit with the data obtained from the batch sorption of AC, OAC, and IDA-OAC. The significant capacity and reusability of IDA-OAC displayed high applicability for water treatment.

Preparation of Metal-Immobilized Methacrylate-Based Monolithic Columns for Flow-Through Cross-Coupling Reactions

With the aim of developing efficient flow-through microreactors for high-throughput organic synthesis, in this work, microreactors were fabricated by chemically immobilizing palladium-, nickel-, iron-, and copper-based catalysts onto ligand-modified poly(glycidyl methacrylate-co-ethylene dimethacrylate) [poly(GMA-co-EDMA)] monoliths, which were prepared inside a silicosteel tubing (10 cm long with an inner diameter of 1.0 mm) and modified with several ligands including 5-amino-1,10-phenanthroline (APHEN), iminodiacetic acid (IDA), and iminodimethyl phosphonic acid (IDP). The performance of the resulting microreactors in Suzuki−Miyaura cross-coupling reactions was evaluated, finding that the poly(GMA-co-EDMA) monolith chemically modified with 5-amino-1,10-phenanthroline as a binding site for the palladium catalyst provided an excellent flow-through performance, enabling highly efficient and rapid reactions with high product yields. Moreover, this monolithic microreactor maintained its good activity and efficiency during prolonged use.

The Curious Case of a Missing Gallbladder: An Unusual Presentation of a Cholecystoduodenal Fistula

Large gallstones could erode through gallbladder wall to nearby structures, causing fistulas, gastric outlet obstruction and gallstone ileus. They typically occur in elderly patients with comorbidities carrying therapeutic challenges. We present a case of a middle-aged woman who was thought to have symptomatic cholelithiasis. Extensive adhesions precluded safe cholecystectomy. While hepatobiliary iminodiacetic acid scan and magnetic resonance imaging with cholangiopancreatography (MRI-MRCP) failed to visualize the gallbladder, computed tomography (CT) was consistent with cholecystoduodenal fistula. A very large gallstone was seen endoscopically in the duodenum, which was broken down into pieces using a large stiff snare.

Analysis on adsorbent for spent solvent treatment by micro-PIXE and EXAFS

The spent PUREX solvent containing U and Pu is generated from the reprocessing process of spent nuclear fuel. The nuclear material removal is important for the safe storage or disposal of the spent solvent. Our previous study revealed that the adsorbent with the iminodiacetic acid (IDA) functional group is one of the most promising materials for designing the nuclear material recovery process. Accordingly, an IDA-type adsorbent was synthesized by using graft polymerization technology or a chemical reaction to improve the adsorption rate and capacity. The synthesized IDA-type adsorbent was characterized by micro particle-induced X-ray emission (PIXE) and extended X-ray absorption fine structure (EXAFS) analyses. The micro-PIXE analysis revealed that Zr was adsorbed on the whole synthesized adsorbents and quantified the microamount of adsorbed Zr. Moreover, EXAFS suggested that Zr in the aqueous solution and solvent can be trapped by the IDA group with different mechanisms.

Evaluation of Insulin-Like Activity of Novel Zinc Metal–Organics toward Adipogenesis Signaling

Diabetes mellitus is a debilitating disease, plaguing a significant number of people around the globe. Attempts to develop new drugs on well-defined atoxic metalloforms, which are capable of influencing fundamental cellular processes overcoming insulin resistance, has triggered an upsurge in molecular research linked to zinc metallodrugs. To that end, meticulous efforts were launched toward the design and synthesis of materials with insulin mimetic potential. Henceforth, trigonelline and N-(2-hydroxyethyl)-iminodiacetic acid (HEIDAH2) were selected as organic substrates seeking binding to zinc (Zn(II)), with new crystalline compounds characterized by elemental analysis, FT-IR, X-rays, thermogravimetry (TGA), luminescence, NMR, and ESI-MS spectrometry. Physicochemical characterization was followed by in vitro biochemical experiments, in which three out of the five zinc compounds emerged as atoxic, exhibiting bio-activity profiles reflecting enhanced adipogenic potential. Concurrently, well-defined qualitative–quantitative experiments provided links to genetic loci responsible for the observed effects, thereby unraveling their key involvement in signaling pathways in adipocyte tissue and insulin mimetic behavior. The collective results (a) signify the quintessential role of molecular studies in unearthing unknown facets of pathophysiological events in diabetes mellitus II, (b) reflect the close associations of properly configured molecular zincoforms to well-defined biological profiles, and (c) set the stage for further physicochemical-based development of efficient zinc antidiabetic metallodrugs.